O-丁基羟胺盐酸盐 | 4490-82-8

• 物质功能分类: 化学试剂 - 有机试剂 - 羟胺
• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: O-丁基羟胺盐酸盐
• 英文名称: butoxyamine hydrochloride
• 英文别名: n-butyloxyamine hydrochloride；O-n-butyl-hydroxylamine hydrochloride；O-butylhydroxylamine hydrochloride；n-butoxyamine hydrochloride；butoxylamine hydrochloride；butoxamine hydrochloride；O-butylhydroxylamine hydrochloride salt；O-butylhydroxylamine;hydrochloride
• CAS: 4490-82-8
• 化学式: C₄H₁₁NO*ClH
• mdl: MFCD00487631
• 分子量: 125.598
• InChiKey: HUYRNQWVAPCTQZ-UHFFFAOYSA-N

物化性质

• 熔点：
  157.0 to 161.0 °C
• 溶解度：
  溶于甲醇

计算性质

• 辛醇/水分配系数(LogP)：
  0.96
• 重原子数：
  7
• 可旋转键数：
  3
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  35.2
• 氢给体数：
  2
• 氢受体数：
  2

安全信息

• 海关编码：
  2922199090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  存放于惰性气体中，并避免接触湿气（吸湿）。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: O-Butylhydroxylamine HCl
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: O-Butylhydroxylamine HCl
CAS number: 4490-82-8

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C4H11NO.ClH
Molecular weight: 125.6

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  O-丁基羟胺盐酸盐 、 对羟基苯乙酮 以 乙醇 为溶剂， 以79%的产率得到(E)-1-(4-hydroxyphenyl)ethanone O-butyloxime
  参考文献：
  名称：

  신규 비스(４―히드록시) 벤조페논 옥심 에테르 유도체 화합물, 이의 제조 방법 및 이를 유효성분으로 포함하는 에스트로겐 수용체 관련 질환 예방 또는 치료용 조성물

  摘要：

  本发明涉及一种新的双(4-羟基)苯甲酮氧基醚衍生物化合物，其制备方法以及包含其作为有效成分的用于预防或治疗雌激素受体相关疾病的组合物。该新的双(4-羟基)苯甲酮氧基醚衍生物化合物通过结合雌激素受体，具有优越的抑制乳腺癌、子宫癌癌细胞的效果，可用作药学组合物或保健品组合物，用于预防或治疗雌激素受体相关疾病。

  公开号：

  KR20170052873A
• 作为产物：
  描述：

  N-butoxyphthalimide 在 甲基肼 、 盐酸 作用下， 以 二氯甲烷 、 1,4-二氧六环 为溶剂， 反应 2.0h， 以100%的产率得到O-丁基羟胺盐酸盐
  参考文献：
  名称：

  NOVEL VASCULAR LEAKAGEAGE INHIBITOR

  摘要：

  本公开涉及一种新型血管渗漏抑制剂。本发明的新型血管渗漏抑制剂抑制血管内皮细胞凋亡，抑制由VEGF诱导的肌动蛋白应激纤维的形成，并增强皮质肌动蛋白环结构，从而抑制血管渗漏。因此，本发明的血管渗漏抑制剂可以预防或治疗由血管渗漏引起的各种疾病。由于本发明的血管渗漏抑制剂是由商业可获得或易于合成的孕酮合成的，因此具有明显优越的商业合成可行性。

  公开号：

  US20140378399A1

文献信息

• Additionen von Organometallverbindungen an die C?N-Bindung
  作者：A. Marxer、M. Horvath

  DOI：10.1002/hlca.19640470421

  日期：——

  The addition of organometallic compounds to SCHIFF bases, hydrazones, and oximes was studied. It is shown that, contrary to statements in the literature, hydra-zones and oximes may give rise to the same type of C-alkylation and C-arylation as already known for SCHIFF bases.

  研究了向SCHIFF碱，和肟中添加有机金属化合物的方法。结果表明，与文献中的陈述相反，水合区和肟可引起与SCHIFF碱已知的相同类型的C-烷基化和C-芳基化。
• Compositions containing 4,5,6,7-tetrahydrobenz[b]thien-4-yl-ureas or
  申请人：American Cyanamid Company

  公开号：US04036979A1

  公开（公告）日：1977-07-19

  This disclosure describes a novel method for improving feed efficiency and accelerating the growth rate of veterinary homothermic animals by administering to said animals a growth-promoting amount of a cycloalkano[b]thien-4-ylurea or thiourea.

  这份披露描述了一种新颖的方法，通过向兽医同温动物投予一定量的环戊烷基硫代脲或硫脲，以提高饲料效率并加快生长速度。
• Tandem Functionalization in a Highly Branched Polymer with Layered Structure
  作者：Xiaosong Cao、Yi Shi、Weiping Gan、Haifeng Gao

  DOI：10.1002/chem.201800683

  日期：2018.4.17

  hyperbranched polymer with multilayer structure was developed to demonstrate the possibility of highly efficient tandem functionalization reactions at different domains within one nanostructured platform. The polymer scaffold was constructed by chain‐growth copper‐catalyzed azide–alkyne cycloaddition polymerization of three functional monomers with sequential monomer addition in one pot. Subsequent reactions

  开发了具有多层结构的超支化聚合物，以证明在一个纳米结构平台内不同区域进行高效串联功能化反应的可能性。该聚合物支架是通过链增长的三种功能单体的链增长铜催化的叠氮化物-炔烃环加成聚合反应构建而成，并在一个罐中依次添加单体。随后与不同单体单元的反应导致每个链段的有效官能化，并通过稳健的程序构建了高度复杂的聚合物结构。作为概念的证明，证明了这种聚合物结构通过三种不同类型的共轭反应定量加载六种客体分子的能力。
• Electrodimerization of <i>N</i>-Alkoxyamides for the Synthesis of Hydrazines
  作者：Abudulajiang Nasier、Xihao Chang、Chang Guo

  DOI：10.1021/acs.joc.1c01294

  日期：2021.11.19

  wide range of advanced, highly functionalized hydrazines. Remarkably, an N-centered radical generated from the cleavage of the N–H bond under electrolytic conditions plays a crucial role in this transformation. Furthermore, various N-alkoxyamides bearing different substituents are suitable in this transformation, furnishing the corresponding hydrazines in up to 92% yield.

  据报道，在未分开的电解条件下，N-烷氧基酰胺的有效且有价值的 N-N 二聚反应。这种电化学策略提供了一种强大的方法来获得各种先进的、高度官能化的肼。值得注意的是，电解条件下 N-H 键断裂产生的N中心自由基在这种转变中起着至关重要的作用。此外，带有不同取代基的各种N-烷氧基酰胺适用于这种转化，以高达 92% 的产率提供相应的肼。
• [EN] NOVEL COMPOUNDS AS AGONIST FOR PPAR GAMMA AND PPAR ALPHA, METHOD FOR PREPARATION OF THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME<br/>[FR] NOUVEAUX COMPOSES AGONISTES DE PPAR DOLLAR G(G) ET PPAR DOLLAR G(A), LEUR METHODE DE PREPARATION ET COMPOSITION PHARMACEUTIQUE LES CONTENANT
  申请人：LG LIFE SCIENCES LTD

  公开号：WO2005040127A1

  公开（公告）日：2005-05-06

  The present invention relates to novel compounds accelerating the activity of Peroxisome proliferator-activated receptor gamma (PPARϜ) and alpha (PPARα), processes of preparing the same, and pharmaceutical compositions containing the same as an active agent.

  本发明涉及一种新型化合物，可加速过氧化物酶体增殖物激活受体γ（PPARϜ）和α（PPARα）的活性，以及制备这种化合物的方法，以及含有该化合物作为活性成分的药物组合物。